<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="Respiratory syncytial virus (RSV) is the leading cause of severe" exact="respiratory disease" post="in infants. Other than age at the time of"/>
 <result pre="risk factors for severe illness include prematurity, bronchopulmonary dysplasia, cyanotic" exact="heart disease," post="neuromuscular disease, and immune compromise 4, 10 . However,"/>
 <result pre="for severe illness include prematurity, bronchopulmonary dysplasia, cyanotic heart disease," exact="neuromuscular disease," post="and immune compromise 4, 10 . However, approximately 70%"/>
 <result pre="pneumoniae, as previously described 40– 42 . Viral targets included" exact="influenza" post="A and B, respiratory syncytial virus (RSV), human metapneumovirus"/>
 <result pre="suggested that gene expression biomarkers of severity are associated with" exact="pneumonia" post="( Fig. 1B). This observation, consistent with the lower"/>
 <result pre="gap in our understanding of the mechanisms involved in infant" exact="respiratory disease," post="in that we rarely have had the opportunity to"/>
 <result pre="Bloom-Feshbach, K. et al. Latitudinal variations in seasonal activity of" exact="influenza" post="and respiratory syncytial virus (RSV): a global comparative review."/>
 <result pre="microbiome impacts severity of lower respiratory infection and risk of" exact="asthma" post="development. Cell Host Microbe 17, 704– 715 , doi:"/>
</results>
